2026 ASCO Annual Meeting

ABOUT THE EVENT

Date: May 29, 2026 - June 2, 2026
Event Location: Chicago, Illinois

The 2026 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Eric Small’s Presidential theme, The Science and Practice of Translation: Improving Cancer Outcomes Worldwide. The meeting program will be available to view in December.

Your all-access pass to the most clinically relevant cancer science. #ASCO26 session highlights include:

  • Plenary Session, featuring the meeting’s most practice-changing and clinically relevant abstract presentations and discussions
  • Opening Session, featuring the Presidential Address and Karnofsky Award and Lecture
  • ASCO Voices
  • 24 Oral Abstract Sessions, 24 Rapid Oral Abstract Sessions, and 13 Clinical Science Symposia, featuring over 450 oral abstract presentations
  • 15 Case-Based Panels, featuring interactive audience polling
  • Joint Sessions with AACR, ASPO, and ECO
  • Over 2,700 Poster presentations, including Trials in Progress
MORE EVENTS
Taking an early proof of concept into preclinical and clinical development is a costly and complex process. But there are strategic ways to streamline the process and reduce risk and costs. In this webinar, you’ll hear directly from Nobel Laureate Sir Michael Houghton and experts from Applied Pharma, who bring decades of real-world success and deep scientific expertise.
Tuesday, February 24, 2026 12–1pm EST
 · 
Virtual
In this webinar, leading oncology experts Dr. Javier Cortés and Dr. Antonio Llombart-Cussac will explore how collaborative-initiated trials are transforming the clinical research landscape and creating new opportunities for scientific and clinical impact.
Monday, March 2, 2026 11am–12pm EST
 · 
Virtual
Artificial intelligence is rapidly reshaping the life sciences, from automating repetitive tasks to enabling advanced scientific and safety assessments across drugs, biologics, and devices. As adoption grows across regulators, pharmaceutical companies, technology developers, nonprofits, and collaborative consortia, the need for clear, risk-based frameworks for validation, governance and human oversight becomes increasingly critical.
Tuesday, March 17, 2026 1–2pm EDT
 · 
Virtual